Logo image of AIDX.CA

HEALWELL AI INC (AIDX.CA) Stock Fundamental Analysis

TSX:AIDX - Toronto Stock Exchange - CA42249X1006 - Common Stock - Currency: CAD

1.42  +0.03 (+2.16%)

Fundamental Rating

2

Taking everything into account, AIDX scores 2 out of 10 in our fundamental rating. AIDX was compared to 15 industry peers in the Health Care Providers & Services industry. AIDX has a bad profitability rating. Also its financial health evaluation is rather negative. While showing a medium growth rate, AIDX is valued expensive at the moment.


Dividend Valuation Growth Profitability Health

Quickly go to:

1

1. Profitability

1.1 Basic Checks

AIDX had negative earnings in the past year.
AIDX had a negative operating cash flow in the past year.
AIDX had negative earnings in each of the past 5 years.
In the past 5 years AIDX reported 4 times negative operating cash flow.
AIDX.CA Yearly Net Income VS EBIT VS OCF VS FCFAIDX.CA Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2017 2018 2019 2020 2021 2022 2023 2024 0 -10M -20M -30M

1.2 Ratios

AIDX's Return On Assets of -31.28% is on the low side compared to the rest of the industry. AIDX is outperformed by 80.00% of its industry peers.
AIDX has a Return On Equity of -55.67%. This is in the lower half of the industry: AIDX underperforms 66.67% of its industry peers.
Industry RankSector Rank
ROA -31.28%
ROE -55.67%
ROIC N/A
ROA(3y)-41.98%
ROA(5y)-31.25%
ROE(3y)-156.63%
ROE(5y)-292.43%
ROIC(3y)N/A
ROIC(5y)N/A
AIDX.CA Yearly ROA, ROE, ROICAIDX.CA Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2017 2018 2019 2020 2021 2022 2023 2024 -200 -400 -600 -800

1.3 Margins

The Gross Margin of AIDX (44.95%) is better than 73.33% of its industry peers.
In the last couple of years the Gross Margin of AIDX has grown nicely.
AIDX does not have Profit Margin and Operating Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 44.95%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y12.28%
GM growth 5Y6.15%
AIDX.CA Yearly Profit, Operating, Gross MarginsAIDX.CA Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2017 2018 2019 2020 2021 2022 2023 2024 0 -100 -200 -300 -400

More info and screens

3

2. Health

2.1 Basic Checks

AIDX does not have a ROIC to compare to the WACC, probably because it is not profitable.
AIDX has more shares outstanding than it did 1 year ago.
The number of shares outstanding for AIDX has been increased compared to 5 years ago.
The debt/assets ratio for AIDX has been reduced compared to a year ago.
AIDX.CA Yearly Shares OutstandingAIDX.CA Yearly Shares OutstandingYearly Shares Outstanding 2018 2019 2020 2021 2022 2023 2024 50M 100M 150M
AIDX.CA Yearly Total Debt VS Total AssetsAIDX.CA Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2018 2019 2020 2021 2022 2023 2024 20M 40M 60M 80M 100M

2.2 Solvency

An Altman-Z score of 2.54 indicates that AIDX is not a great score, but indicates only limited risk for bankruptcy at the moment.
AIDX has a Altman-Z score of 2.54. This is in the better half of the industry: AIDX outperforms 73.33% of its industry peers.
A Debt/Equity ratio of 0.17 indicates that AIDX is not too dependend on debt financing.
Looking at the Debt to Equity ratio, with a value of 0.17, AIDX belongs to the top of the industry, outperforming 93.33% of the companies in the same industry.
Industry RankSector Rank
Debt/Equity 0.17
Debt/FCF N/A
Altman-Z 2.54
ROIC/WACCN/A
WACC7.88%
AIDX.CA Yearly LT Debt VS Equity VS FCFAIDX.CA Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2017 2018 2019 2020 2021 2022 2023 2024 0 20M -20M 40M 60M

2.3 Liquidity

AIDX has a Current Ratio of 0.97. This is a bad value and indicates that AIDX is not financially healthy enough and could expect problems in meeting its short term obligations.
The Current ratio of AIDX (0.97) is better than 73.33% of its industry peers.
A Quick Ratio of 0.97 indicates that AIDX may have some problems paying its short term obligations.
AIDX has a Quick ratio of 0.97. This is in the better half of the industry: AIDX outperforms 80.00% of its industry peers.
Industry RankSector Rank
Current Ratio 0.97
Quick Ratio 0.97
AIDX.CA Yearly Current Assets VS Current LiabilitesAIDX.CA Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2018 2019 2020 2021 2022 2023 2024 5M 10M 15M 20M

More info and screens

5

3. Growth

3.1 Past

The Earnings Per Share has grown by an impressive 62.74% over the past year.
AIDX shows a strong growth in Revenue. In the last year, the Revenue has grown by 469.50%.
The Revenue has been decreasing by -3.38% on average over the past years.
EPS 1Y (TTM)62.74%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-33.33%
Revenue 1Y (TTM)469.5%
Revenue growth 3Y-6.59%
Revenue growth 5Y-3.38%
Sales Q2Q%207.67%

3.2 Future

The Earnings Per Share is expected to grow by 25.99% on average over the next years. This is a very strong growth
The Revenue is expected to grow by 55.13% on average over the next years. This is a very strong growth
EPS Next Y71.31%
EPS Next 2Y39.53%
EPS Next 3Y25.99%
EPS Next 5YN/A
Revenue Next Year250.29%
Revenue Next 2Y122.26%
Revenue Next 3Y76.98%
Revenue Next 5Y55.13%

3.3 Evolution

The Revenue growth rate is accelerating: in the next years the growth will be better than in the last years.
AIDX.CA Yearly Revenue VS EstimatesAIDX.CA Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2031 2032 200M 400M 600M
AIDX.CA Yearly EPS VS EstimatesAIDX.CA Yearly EPS VS EstimatesYearly EPS VS Estimates 2020 2021 2022 2023 2024 2025 2026 0 -0.1 -0.2 -0.3 -0.4

More info and screens

1

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings Ratio is negative for AIDX. In the last year negative earnings were reported.
Besides the negative Price/Earnings Ratio, also the Forward Price/Earnings Ratio is negative for AIDX. No positive earnings are expected for the next year.
Industry RankSector Rank
PE N/A
Fwd PE N/A
AIDX.CA Price Earnings VS Forward Price EarningsAIDX.CA Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 50 -50

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
AIDX.CA Per share dataAIDX.CA EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 0.2 -0.2

4.3 Compensation for Growth

A more expensive valuation may be justified as AIDX's earnings are expected to grow with 25.99% in the coming years.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y39.53%
EPS Next 3Y25.99%

More info and screens

0

5. Dividend

5.1 Amount

AIDX does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

HEALWELL AI INC

TSX:AIDX (8/7/2025, 7:00:00 PM)

1.42

+0.03 (+2.16%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Providers & Services
Earnings (Last)05-13 2025-05-13/bmo
Earnings (Next)08-18 2025-08-18
Inst Owners0.06%
Inst Owner ChangeN/A
Ins Owners14.83%
Ins Owner ChangeN/A
Market Cap391.78M
Analysts83.53
Price Target3.52 (147.89%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DP0%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)0
Avg EPS beat(2)-269.05%
Min EPS beat(2)-467.59%
Max EPS beat(2)-70.5%
EPS beat(4)1
Avg EPS beat(4)-102.5%
Min EPS beat(4)-467.59%
Max EPS beat(4)158.83%
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)0
Avg Revenue beat(2)-1.78%
Min Revenue beat(2)-3%
Max Revenue beat(2)-0.56%
Revenue beat(4)1
Avg Revenue beat(4)-0.08%
Min Revenue beat(4)-3%
Max Revenue beat(4)3.32%
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)-9.36%
EPS NQ rev (1m)0%
EPS NQ rev (3m)19.63%
EPS NY rev (1m)0%
EPS NY rev (3m)0%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)-3.22%
Revenue NY rev (1m)-1.44%
Revenue NY rev (3m)-3.3%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 7.38
P/FCF N/A
P/OCF N/A
P/B 5.45
P/tB N/A
EV/EBITDA N/A
EPS(TTM)-0.34
EYN/A
EPS(NY)-0.02
Fwd EYN/A
FCF(TTM)-0.08
FCFYN/A
OCF(TTM)-0.08
OCFYN/A
SpS0.19
BVpS0.26
TBVpS-0.07
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -31.28%
ROE -55.67%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 44.95%
FCFM N/A
ROA(3y)-41.98%
ROA(5y)-31.25%
ROE(3y)-156.63%
ROE(5y)-292.43%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y12.28%
GM growth 5Y6.15%
F-Score5
Asset Turnover0.41
Health
Industry RankSector Rank
Debt/Equity 0.17
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr 17.07%
Cap/Sales 2.43%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 0.97
Quick Ratio 0.97
Altman-Z 2.54
F-Score5
WACC7.88%
ROIC/WACCN/A
Cap/Depr(3y)14.05%
Cap/Depr(5y)20.98%
Cap/Sales(3y)2.16%
Cap/Sales(5y)2.4%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)62.74%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-33.33%
EPS Next Y71.31%
EPS Next 2Y39.53%
EPS Next 3Y25.99%
EPS Next 5YN/A
Revenue 1Y (TTM)469.5%
Revenue growth 3Y-6.59%
Revenue growth 5Y-3.38%
Sales Q2Q%207.67%
Revenue Next Year250.29%
Revenue Next 2Y122.26%
Revenue Next 3Y76.98%
Revenue Next 5Y55.13%
EBIT growth 1Y-44.07%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year109.02%
EBIT Next 3Y41.86%
EBIT Next 5Y33.78%
FCF growth 1Y-204.95%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-218.93%
OCF growth 3YN/A
OCF growth 5YN/A